Cargando…

A single birth dose of Hepatitis B vaccine induces polyfunctional CD4(+) T helper cells

A single birth-dose of Hepatitis B vaccine (HepB) can protect newborns from acquiring Hepatitis B infection through vertical transmission, though several follow-up doses are required to induce long-lived protection. In addition to stimulating antibodies, a birth-dose of HepB might also induce polyfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Strandmark, Julia, Darboe, Alansana, Diray-Arce, Joann, Ben-Othman, Rym, Vignolo, Sofia M., Rao, Shun, Smolen, Kinga K., Leroux-Roels, Geert, Idoko, Olubukola T., Sanchez-Schmitz, Guzmán, Ozonoff, Al, Levy, Ofer, Kollmann, Tobias R., Marchant, Arnaud, Kampmann, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681035/
https://www.ncbi.nlm.nih.gov/pubmed/36426360
http://dx.doi.org/10.3389/fimmu.2022.1043375
Descripción
Sumario:A single birth-dose of Hepatitis B vaccine (HepB) can protect newborns from acquiring Hepatitis B infection through vertical transmission, though several follow-up doses are required to induce long-lived protection. In addition to stimulating antibodies, a birth-dose of HepB might also induce polyfunctional CD4(+) T-cells, which may contribute to initial protection. We investigated whether vaccination with HepB in the first week of life induced detectable antigen-specific CD4(+) T-cells after only a single dose and following completion of the entire HepB vaccine schedule (3 doses). Using HBsAg- stimulated peripheral blood mononuclear cells from 344 infants, we detected increased populations of antigen-specific polyfunctional CD154(+)IL-2(+)TNFα(+) CD4(+) T-cells following a single birth-dose of HepB in a proportion of infants. Frequencies of polyfunctional T-cells increased following the completion of the HepB schedule but increases in the proportion of responders as compared to following only one dose was marginal. Polyfunctional T-cells correlated positively with serum antibody titres following the birth dose (day30) and completion of the 3-dose primary HepB vaccine series (day 128). These data indicate that a single birth dose of HepB provides immune priming for both antigen-specific B- and T cells